Healthcare

Mesoblast Ltd (ASX:MSB) is a name that appears on the watchlists of many market participants following Australian healthcare and biotechnology stocks. Its performance is closely tied to broader healthcare and biotechnology sector dynamics and the general mood across equity markets.

Cogstate Ltd (ASX:CGS) is a name that appears on the watchlists of many market participants following Australian healthcare and biotechnology stocks. Its performance is closely tied to broader healthcare and biotechnology sector dynamics and the general mood across equity markets.

4DMedical Ltd (ASX:4DX) is a name that appears on the watchlists of many market participants following Australian healthcare and biotechnology stocks. Its performance is closely tied to broader healthcare and biotechnology sector dynamics and the general mood across equity markets.

No single company-specific catalyst had been confirmed from the public disclosures reviewed for this article at the time of writing. The commentary below outlines what the company does, its position on the available snapshot metrics, the sector backdrop and the factors investors may wish …

No single company-specific catalyst had been confirmed from the public disclosures reviewed for this article at the time of writing. The commentary below outlines what the company does, its position on the available snapshot metrics, the sector backdrop and the factors investors may wish …

Australian Clinical Labs (ASX: ACL) shares gained 6.17% to $2.41 during intraday trading on 16 July 2026. The company operates within the healthcare sector, providing pathology and diagnostic testing services across Australia.

Mesoblast (ASX: MSB) was among the stronger performers on the Australian sharemarket on 16 July 2026, with its shares climbing 4.83% to AUD 2.72 in intraday trading around 1:56pm AEST (20-minute delayed data). The regenerative medicine biotechnology company attracted buying interest despite weakness across …